Caterpillar Names Dr. Lou Balmer-Millar As Its Chief Sustainability Officer – $CAT $DIA $INVO

By John F. Heerdink, Jr.

As per reports, Caterpillar Inc.’s (CAT) Dr. Lou Balmer-Millar will now also lead as the Chief Sustainability Officer in addition to her current responsibility as Senior VP of the Large Power Systems Division within the Energy and Transportation segment. Balmer-Millar will succeed Julie Lagacy, who is retiring on February 1, 2023, after nearly 35 years of dedicated service. Dr. Lou Balmer-Millar will report directly to Chairman and CEO Jim Umpleby.

“Sustainability is an important focus area of our long-term strategy for profitable growth. Building on her role in Caterpillar’s Energy & Transportation segment, this move further enhances the advancement of product solutions to support our customers during the energy transition and help them achieve their climate-related objectives by geography, application, and specific customer needs. We remain committed to helping our customers build a better, more sustainable world,”stated Caterpillar Chairman and CEO Jim Umpleby.

Dow 30 Component Caterpillar, Inc. (CAT) is the world’s chief manufacturer of diesel and natural gas engines, construction and mining equipment, industrial gas turbines, and diesel-electric locomotives. Caterpillar, Inc. also works to make sustainable progress possible and contributes to driving positive change on every continent. To learn more about Caterpillar, Inc. (CAT) and to continue to track its progress please visit the Vista Partners Caterpillar, Inc. Coverage Page.

Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.

DID YOU KNOW?

Fertility rates have hit a record low in the United States. The latest US government fertility statistics come from 2019, and they estimate there were 58.2 births year per 1,000 women of childbearing age (defined by the CDC as women between ages 15 and 44).

If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently.